http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201603820-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f4c0d2edd086f23a9812b347a09dfb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79eb8dfab795b50a6aa8b92ee08099e2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2014-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5289e8358a9f9fc6e084c7fd708fb9a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0643ad7529c946e481d57e60359a8a84 |
| publicationDate | 2016-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201603820-A |
| titleOfInvention | Use of Rhodiola aqueous extract for preparing a pharmaceutical composition for improving chronic obstructive pulmonary disease |
| abstract | The present invention relates to a use of a composition of Rhodiola aqueous extract for improving chronic obstructive pulmonary disease, the composition comprising an agent for treating bronchial and pulmonary swelling, which can be used for improving CAT values of patients with chronic obstructive pulmonary disease The improvement mechanism is an immune response of CD8 surface antigen T cells, which may include an immune mechanism induced by down-regulation of Th1 helper cells, and an immune pathway including up-regulation of CD4, CD25, FOXP3 surface antigen or CD4, CD25, CD45, FOXP3 surface antigens. . |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I742699-B |
| priorityDate | 2014-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 273.